Here are 10 things you should know about how Americans are thinking about weight loss, and how the anti-obesity market could shape up, based on a 388-person survey by VC firm Coefficient Capital and tech outlet The New Consumer, and a study by Morgan Stanley
If you are struggling with hypoglycemia after starting semaglutide, talk with your doctor
For accurate and up-to-date pricing, its best to contact our specialist, Dr
A dose adjustment or switch to a different medication may be appropriate
Cavezzi A, Troiani E, Corrao S
Discontinuation of treatment due to gastrointestinal adverse events was more frequent with any dose of tirzepatide (risk ratios ranging from 6.39 to 10.65) or semaglutide (risk ratios ranging from 4.99 to 8.91) compared with placebo (Fig